News and Announcements
EDITORIAL
Recent advances in pediatric cancer research: An overview
Show Less
1 Department of Biostatistics, Florida International University Stempel College of Public Health and Social Work, Miami,
United States of America
2 Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, Utah,
United States of America
Tumor Discovery, 025410108 https://doi.org/10.36922/TD025410108
Received: 9 October 2025 | Accepted: 15 October 2025 | Published online: 30 October 2025
(This article belongs to the Special Issue Current Advances in Pediatric Cancer Diagnoses and Treatments)
© 2025 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Conflict of interest
Nan Hu is an Editorial Board Member of this journal and the Guest Editor of this special issue, and declared that he has no known competing financial interests or personal relationships that could have influenced the work reported in this paper.
References
- World Health Organization (WHO). Childhood Cancer Drug Current Landscape and Pipeline Characteristics. Available from: https://www.who.int/observatories/ global-observatory-on-health-research-and-development/monitoring/pediatric-cancer-drug-pipeline-characteristics?utm_source=chatgpt.com [Last accessed on 2025 Sep 30].
- Nass SJ, Balogh E, Mendelsohn J. A national cancer clinical trials network: Recommendations from the institute of medicine. Am J Ther. 2011;18(5):382-391. doi: 10.1097/MJT.0b013e3181ff7e23
- Van Heerden J, Zaghloul M, Neven A, et al. Pediatric oncology clinical trials and collaborative research in Africa: Current landscape and future perspectives. JCO Glob Oncol. 2020;6:1264-1275. doi: 10.1200/GO.20.00159
- Godbole S, Voß H, Gocke A, et al. Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level. Nat Commun. 2024;15(1):6237. doi: 10.1038/s41467-024-50554-z
- Cheng C, Zhang L, Chang X, et al. Integrative proteogenomic characterization of Wilms tumor. Nat Commun. 2025;16(1):7715. doi: 10.1038/s41467-025-62234-7
- Grigore FN, Yang SJ, Chen CC, Koga T. Pioneering models of pediatric brain tumors. Neoplasia. 2023;36:100859. doi: 10.1016/j.neo.2022.100859
- Lau LMS, Khuong-Quang DA, Mayoh C, et al. Precision-guided treatment in high-risk pediatric cancers. Nat Med. 2024;30(7):1913-1922. doi: 10.1038/s41591-024-03044-0
- Acanda De La Rocha AM, Berlow NE, et al. Feasibility of functional precision medicine for guiding treatment of relapsed or refractory pediatric cancers. Nat Med. 2024;30(4):990-1000. doi: 10.1038/s41591-024-02848-4
- Henrikson NB, Morrison CC, Blasi PR, Nguyen M, Shibuya KC, Patnode CD. Behavioral counseling for skin cancer prevention: Evidence report and systematic review for the US preventive services task force. JAMA. 2018;319(11):1143-1157. doi: 10.1001/jama.2017.21630
- Bezerra PMM, Sampaio MEA, Dos Santos FG, Ribeiro ILA, Santiago BM, de Sousa SA, Valença AMG. The effectiveness of an oral health education and prevention program on the incidence and severity of oral mucositis in pediatric cancer patients: A non-randomized controlled study. Support Care Cancer. 2021;29(12):7877-7885. doi: 10.1007/s00520-021-06387-3
- Ilowite MF, Cronin AM, Kang TI, Mack JW. Disparities in prognosis communication among parents of children with cancer: The impact of race and ethnicity. Cancer. 2017;123(20):3995-4003. doi: 10.1002/cncr.30960